Medical Marijuana Market: Key Takeaway from Assessment Analysis

A new research study from HTF MI with title Medical Marijuana - Thematic Research provides an in-depth assessment of the Medical Marijuana - Thematic including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles and strategies. The research study provides forecasts for Medical Marijuana - Thematic market till 2025.

Access Sample Copy @: https://www.htfmarketreport.com/sample-report/2336827-medical-marijuana-thematic-research

Summary
"GlobalData’s Medical Marijuana Thematic Analysis report combines key opinion leader insight, interviews with industry experts and surveys of prescribing physicians and consumers in the US, France, Germany, Italy, Spain, the UK, Canada, Israel and Australia to provide an in-depth review of the medical marijuana market.
The medical marijuana market is expected to grow at a CAGR of 81.3% between 2018 and 2025. Growth in the medical marijuana market will be driven by the approval of marketed drugs in additional markets. For example, Epidiolex is approved in the US and recently launched in France, Germany and the UK. The drug, which is used to treat refractory childhood-onset epilepsies is expected to launch in Spain and Italy, among other markets in 2020. Similarly, GW Pharma's Sativex is approved for muscle spasticity in patients with multiple sclerosis in many European markets and is at the pre-registration stage in the US. Launching in this market will drive sales. Furthermore, label expansion opportunities and the launch of novel agents in the coming years will lead to explosive growth making the market value worth an estimated $3.2B by 2025.

Buy this research report @ https://www.htfmarketreport.com/buy-now?format=1&report=2336827

Key Highlights
- The medical marijuana market is expected to grow at a CAGR of 81.3% from 2018 to 2025. The launch of pipeline agents Zygel and lenabasum will add to the number of products in the market which will reaching a global value of $3.2 billion in 2025.

- There are currently five approved medical marijuana therapies across the countries discussed in this report (US, France, Germany, Italy, Spain, UK, Canada, Israel and Australia). The products are Epidiolex, Marinol, Sativex, Nabilone and Syndros. The main issues presented are the fact that Epidiolex and Sativex are unaffordable without coverage from health insurance policies. The THC-content of products like Marinol also presents a barrier to approval in markets other than the US. This is because of its psychoactive properties. Another clinical obstacle is the tolerability of oromucosal sprays as pediatric patients can have difficulty with the taste of these therapies.

Scope
- Overview of the potential applications of medical marijuana including SWOT analysis of marketed and late-stage pipeline agents

- In-depth analysis of diseases where at least one medical marijuana product is used in clinical practice

- Key topics covered include assessment of strategic consolidations, unmet needs, clinical trial mapping, examination of market opportunities and challenges

- Discussion of late-stage pipeline products including a sales forecast from 2018-2025

- Pipeline analysis: comprehensive data and discussion of emerging trends, the significance of the endocannabinoid system in various conditions, the route of administration of pipeline agents and the markets in which the drugs are expected to launch.

Early buyers will receive 10% customization on reports. Read Detailed Index of full Research Study at @ https://www.htfmarketreport.com/reports/2336827-medical-marijuana-thematic-research

Major companies covered in the report: - Albany Molecular Research, Almirall, Axim Biotechnologies, Bionorica, Cannabis Science, Ci Therapeutics, Corbus Pharma, Eli Lilly, Emerald Bioscience, Emerald Health Sciences, GW Pharma, Insys Therapeutics, Ipsen, LTS Lohmann Therapie-Systeme, Neopharm, Novaliq, One World Cannabis, Panaxia, RespireRx, STERO Biotechs, SUDA Pharma, Tetra-Bio Pharma, Teva, Therapix Biosciences, Unimed Pharma, Veritas, Yom Chai & Zynerba Pharma

This study also contains company profiling, product picture and specifications, sales, market share and contact information of various international, regional, and local vendors of Medical Marijuana - Thematic Market. The market competition is constantly growing higher with the rise in technological innovation and M&A activities in the industry. Moreover, many local and regional vendors are offering specific application products for varied end-users. The new vendor entrants in the market are finding it hard to compete with the international vendors based on quality, reliability, and innovations in technology.

Some of the key questions answered in this report:
- Detailed Overview of Medical Marijuana - Thematic market helps deliver clients and businesses making strategies.
- Influential factors that are thriving demand and constraints in the market.
- What is the market concentration? Is it fragmented or highly concentrated?
- What trends, challenges and barriers will impact the development and sizing of Medical Marijuana - Thematic market?
- SWOT Analysis of each key players mentioned along with its company profile with the help of Porter’s five forces tool mechanism to compliment the same.
- What growth momentum or acceleration market carries during the forecast period?
- Which region is going to tap highest market share in future?
- What Application/end-user category or Product Type may see incremental growth prospects?
- What would be the market share of key countries like United States, France, UK, Germany, Italy, Canada, Australia, Japan, China or Brazil etc.?
- What focused approach and constraints are holding the market tight?

Make inquiry before purchase @ https://www.htfmarketreport.com/enquiry-before-buy/2336827-medical-marijuana-thematic-research

There are 15 Chapters to display the Medical Marijuana - Thematic market.
Chapter 1, About Executive Summary to describe Definition, Specifications and Classification of Medical Marijuana - Thematic market, Applications [Application 1, Application 2, Application 3], Market Segment by Regions;
Chapter 2, to analyze objective of the study.
Chapter 3, to display Research methodology and techniques.
Chapter 4 and 5 , to show the Overall Market Analysis, segmentation analysis, characteristics;
Chapter 6 and 7, to show the Market size, share and forecast; Five forces analysis (bargaining Power of buyers/suppliers), Threats to new entrants and market condition;
Chapter 8 and 9, to show analysis by regional segmentation[North America, South America, Asia, Europe & Others], comparison, leading countries and opportunities; Regional Marketing Type Analysis, Supply Chain Analysis
Chapter 10, focus on identifying the key industry influencer’s, overview of decision framework accumulated through Industry experts and strategic decision makers;
Chapter 11 and 12, Market Trend Analysis, Drivers, Challenges by consumer behavior, Marketing Channels and demand & supply.
Chapter 13 and 14, describe about the vendor landscape (classification and Market Positioning)
Chapter 15, deals with Medical Marijuana - Thematic Market sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Contact US :
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
sales@htfmarketreport.com

Connect with us at LinkedIn | Facebook | Twitter

About Author:
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.

This release was published on openPR.